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Aim of the study: To evaluate a novel esophageal heat transfer device for use in inducing,maintaining, and
reversing hypothermia. We hypothesized that this device could successfully induce, maintain (within a
1 ◦C range of goal temperature), and reverse, mild therapeutic hypothermia in a large animal model over
a 30-h treatment protocol.
Methods: Five femaleYorkshire swine,weighing ameanof 65kg (range61–70) kg each,were anesthetized
with inhalational isoﬂurane via endotracheal intubation and instrumented. The esophageal device was
connected to an external chiller and then placed into the esophagus and connected to wall suction.
Reduction to goal temperature was achieved by setting the chiller to cooling mode, and a 24h cooling
protocol was completed before rewarming and recovering the animals. Histopathologic analysis was
scheduled for 3–14 days after protocol completion.
Results: Average baseline temperature for the 5 animals was 38.6 ◦C (range 38.1–39.2 ◦C). All swine were
cooled successfully, with average rate of temperature decrease of 1.3 ◦C/h (range 1.1–1.9) ◦C/h. Standard
deviation from goal temperature averaged 0.2 ◦C throughout the steady-statemaintenance phase, and no
treatment for shivering was necessary during the protocol. Histopathology of esophageal tissue showed
no adverse effects from the device.
Conclusion: A new esophageal heat transfer device successfully and safely induced, maintained, and
reversed therapeutic hypothermia in large swine. Goal temperature was maintained within a narrow
range, and thermogenic shivering did not occur. These ﬁndings suggest a useful new modality to induce
therapeutic hypothermia.
The A© 2013 A Spanish translated version of the abstract of this article appears as Appendix
n the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2012.08.336.
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Open access under CC BY-uthors. Published by Elsevier Ireland Ltd.
1. Introduction
Induction of hypothermia (a 4 ◦C decrease from baseline)
demonstrably improves outcomes in at least twoclinical conditions
(adults resuscitated from cardiac arrest and neonates suffering
from hypoxic ischemic encephalopathy), and appears to be of
beneﬁt in others.1–7 Nevertheless, the overall use of therapeutic
hypothermia has remained relatively low.8–11 The most common
methods currently used to induce hypothermia typically require
skin contact (with blankets, pads, or ice packs, for example) or
intravascular access (for the placement of intravascular cooling
Open access under CC BY-NC-SA license. catheters); limitations or complexities inherent to these methods
may contribute to the underuse of treatment.9
Because new, less-complicated approaches to temperature
control may improve adoption of therapeutic hypothermia, we
NC-SA license. 
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valuated a novel esophageal heat transfer device for use in
nducing and maintaining hypothermia. This esophageal device
s designed to replace the standard orogastric tube, maintain-
ng its functionality for gastric suctioning and decompression,
hile additionally connecting to an external heat exchanger.
emperature-controlled water is supplied in a closed-circuit path-
ay of channels surrounding the central gastric access lumen,
hereby enabling a transfer of heat to or from the patient.12,13 We
ypothesized that this device could successfully induce, maintain
within a 1 ◦C range of goal temperature), and reverse, mild thera-
eutic hypothermia in a large animal model over a 30-h treatment
rotocol.
. Materials and methods
This was a prospective interventional study performed by an
xperienced research team under a protocol approved by the
nstitutional Animal Care Committee of the Minneapolis Medi-
al Research Foundation of Hennepin County Medical Center. The
tudy utilized methods consistent with current veterinary and
SDA standards, with a state-of-the-art, Association for Assess-
ent and Accreditation of Laboratory Animal Care (AAALAC)
nternational-accredited vivarium. Animal care and handling was
n accord with Ofﬁce of Laboratory Animal Welfare guidance for
umane care and use of animals and with regulations outlined in
he USDA Animal Welfare Act (9 CFR Parts 1, 2 and 3) and the con-
itions speciﬁed in the Guide for the Care and Use of Laboratory
nimals (National Academy Press, Washington DC, 1996). Animal
xperimentationwas required todemonstrate the invivo feasibility
f safely and effectively inducing, maintaining, and reversing ther-
peutic hypothermia with this approach, because no alternative
n vitro model can replicate the human cardiovascular physiol-
gy involved. The swine model was chosen for its similarity in
ize, physiology, and thoracic anatomy to humans, and because
wine are a well-accepted model of the human cardiovascular sys-
em, with similar organ arrangement to humans (speciﬁcally with
espect to theaorta, carotids, venacava, azygos, andpulmonaryves-
els in relation to the esophagus). For this experiment, the swine
id not undergo cardiac arrest, since the objective was to evaluate
he performance and safety of the device, rather than the effec-
iveness of therapeutic hypothermia in treating post cardiac arrest
eurologic injury.
.1. Anesthesia, preparation, and monitoring
Five female Yorkshire Crossbred Swine with a mean weight of
5 kg (range 61–70kg), were selected for this study. This num-
er was chosen after including input from the U.S. Food and Drug
dministration, and by attempting to balance a desire to demon-
trate efﬁcacy while identifying signiﬁcant safety ﬁndings within
he constraints of the funding available for this study; however,
o formal estimates of precision on performance parameters were
ndertaken a priori. After acclimation to the facility for at least 2
ays, and with 12h food restriction but free access to water before
he investigation, swine were pre-medicated with intramuscular
etamine (10–15mg/kg of Ketaset, Fort Dodge Animal Health, Fort
odge, Iowa) followed by inhaled isoﬂurane at 0.6–2.5%. The swine
ere endotracheally intubated with a size 7.0 endotracheal tube.
ormal saline (warmed to∼37 ◦C to avoid enhancement of cooling
ffect producedby thedevicebeing studied)was instilled at amain-
enance rate (2 cc/kg/h) via ear vein, and all animals received an
ntravenous heparin bolus (100units/kg) and 500units of heparin
very hour until the study was completed. Using aseptic surgical
onditions, amicromanometer-tipped (Mikro-Tip Transducer, Mil-
ar Instruments, Houston, Texas) catheter was placed at the rightFig. 1. Esophageal heat transfer device.
femoral artery to the beginning of the descending thoracic aorta
to obtain central aortic blood pressure, and an intravascular ther-
mistor was placed at the left femoral vein and advanced to the
inferior vena cava to obtain core swine temperature. Surface elec-
trocardiographic tracings were continuously recorded, and all data
was recorded with a digital recording system (BIOPAC MP 150,
BIOPACSystems, Inc., CA,USA). End tidalCO2 (ETCO2), tidal volume,
minuteventilation, andbloodoxygen saturationwere continuously
measured with a respiratory monitor (CO2SMO Plus, Novametrix
Medical Systems, Wallingford, Connecticut).
2.2. Measurements
Temperature was recorded continuously via an intravascular
Biopac TSD202A Fast Response Thermistor. In addition, temper-
ature measurements were obtained and manually recorded via
rectal thermistor and temperature-sensing Foley catheter (Bard
Medical) placed either in thebladder or in the vaginal vault. Bladder
catheter placement was trans-urethral in two swine and suprapu-
bic in three. Temperatures fromall sensorswere recordedmanually
at 15min intervals during active cooling and rewarming, and at
30min intervalsduring the24hof steady-stateperiod. Serumblood
chemistries via arterial blood gas analysis were measured at inter-
vals throughout the 30h protocol.
2.3. Experimental protocol
The esophageal heat transfer device (Fig. 1) is designed to be
placed through the mouth into the esophagus, and is made of
extruded medical-grade silicone, similar in size and shape to a
large orogastric or Ewald tube (70 cm length and 1.2 cm diameter).
Within the device are lumens to provide pathways for the ﬂow
of water from an external heat exchanger, and a central lumen to
allow suction and decompression of the stomach. The thin walls of
the device allow adequate heat transfer while still remaining rigid
enough to prevent ballooning, and the ﬂow of water internally is
parallel countercurrent.
After anesthesia and preparation, the esophageal heat transfer
device was connected to an external heat exchange unit (Gaymar
Medi-Therm III, Gaymar industries, Inc., Orchard Park, New York).
The chiller, which uses distilledwater as the coolant, was turned on
tobegin circulating coolant through thedevice. The tip of thedevice
was lubricatedwith awater soluble lubricant and inserted through
the oropharynx into the esophagus to the depth determined by
external measurement in a similar fashion to the placement of
standard orogastric tubes. Conﬁrmation of adequate placement
was conﬁrmed by auscultation of stomach sounds during insufﬂa-
tion of air via syringe, successful withdrawal of stomach contents
through the central gastric access pathway within the device, and
itation
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uoroscopic imaging to provide visual conﬁrmation of placement.
ow intermittent wall suction was then connected to the gastric
utlet to provide gastric decompression.
After tracheal injury from prolonged contact with the endo-
racheal tube cuff balloon was discovered on necropsy of the
econd study animal, the protocol was amended to include the
ecommended practice during prolonged tracheal intubation of
eriodicallymeasuringendotracheal tube cuff balloonpressure and
aintaining balloon pressure less than 20 cm H2O.
.4. Cooling
After the completionof swinepreparation, instrumentation, and
lacement of the esophageal heat transfer device, the chiller was
et to cooling mode to initiate induction of hypothermia. The cool-
ng objective was a reduction in body temperature to that of mild
herapeutic hypothermia (4 ◦C below normal body temperature).
.5. Maintenance
Upon reaching goal temperature, each animal was then main-
ained at that goal temperature via the external chiller for a total
f 24h from the start of cooling. During this time, the swine were
anually rotated from one side to the other every 4h to prevent
ressure injuries to skin.
.6. Warming and recovery
Twenty-four hours after the start of cooling, rewarmingwas ini-
iated by setting the chiller to warming mode. Swine were left
ncovered for at least the ﬁrst 2h of warming to establish the
ewarming capability of the esophageal heat transfer device, but
assivewarmingwas addedwith blankets subsequently to support
ore rapid rewarming and recovery of the animals. Once swine
emperature surpassed 36 ◦C, recovery procedures were initiated,
onitoring instruments were removed, and weaning of isoﬂurane
ommenced. Swine were extubated once assessed for their ability
o maintain independent respiratory effort with adequate arte-
ial saturation (>92%) and end tidal CO2 production (>32mmHg),
nd transferred to their cages while spontaneously breathing and
lightly sedated for additional monitoring every 20min for 2h
efore being left alone overnight. Animals were given an intra-
uscular analgesic injection of non-steroidal anti-inﬂammatory
edication (Flunixin) at recovery as well as the day after, and had
ree access to water and food.
.7. Histopathological analysis
Swine were scheduled for sacriﬁce at either 3 or 14 days after
ecovery for gross pathological and histological analysis, with par-
icular attention to the integrity of esophageal mucosal tissue
nd adjacent organs after the experimental temperature modiﬁca-
ion. The time points for analysis were determined from guidance
ffered by the U.S. Food and Drug Administration, with analy-
es performed by an independent board-certiﬁed and licensed
eterinarian and by an independent board-certiﬁed and licensed
eterinary pathologist.
.8. Data
The outcome measure was swine temperature, with speciﬁc
ttention to the rates of temperature change during cooling and
arming, as well as the variation around goal temperature dur-
ng steady-state maintenance of hypothermia. Data are reported
raphically as means, with standard deviation error bars, with84 (2013) 1619–1624 1621
variation around goal temperature reported as the standard devi-
ation of temperature measurements.
3. Results
Five swine were studied from April to June 2012 according to
the experimental protocol. The weight of each animal, along with
temperature at baseline prior to preparation, temperature at start
of cooling, goal temperature, cooling rate, andvariationaroundgoal
temperature at steady-state, are shown in Table 1. Fig. 2 shows
temperature versus time plots for the 5 animals.
3.1. Cooling
Placement time for theesophagealheat transferdevicewasmin-
imal, typically taking less than 1min to pass the device through the
oropharynx, into the esophagus, and to the stomach. All 5 swine
were cooled successfully, with average baseline temperature prior
to initiation of inhalational anesthesia for the 5 animals of 38.6 ◦C
(range 38.1–39.2 ◦C) (Table 1). After anesthesia, swine tempera-
ture dropped an average of 1.2 ◦C (range 0.3–2.6 ◦C) due to heat
losses that are known to occur from inhalational anesthesia and
also during animal preparation and exposure for vascular access;
this drop was largest for the ﬁrst subject (2.6 ◦C), due to a longer
than expected preparation time as the team performed the proto-
col for the ﬁrst time. The average rate of temperature decrease was
1.3 ◦C/h (range 1.1–1.9 ◦C/h).
Although our protocol included the option to use pancuronium
if needed to stop thermogenic shivering (which is known to pre-
vent successful induction of hypothermia), none occurred in any
of the study subjects. Consequently, no swine received pancuro-
nium during any stage (cooling, maintenance, or warming) of the
protocol.
3.2. Maintenance
Average deviation from goal temperature was 0.2 ◦C, (range
0.03–0.48 ◦C) across all animals during the maintenance phase of
the study (Table 1). Swine #5 had the largest standard deviation
around goal temperature, due to problems encountered with the
connector on the temperature probe,which had been sterilized and
re-used between subjects.
3.3. Warming
Because swine had not suffered cardiac arrest and were not
being treated with hypothermia for its known therapeutic bene-
ﬁts (in which slow rewarming is necessary to optimize outcome),
swine were rewarmed at the maximum rate provided by the
esophageal heat transfer device. Warming rates during the ﬁrst 2h
(using only the esophageal heat transfer device) averaged 0.4 ◦C/h
(range 0.25–0.6 ◦C/h).
3.4. Recovery and histopathology
All swine were recovered from anesthesia successfully and
transferred to cages while spontaneously breathing; however,
Swine #2 was noted to have labored breathing and suffered a
respiratory arrest approximately 4h after completion of the pro-
tocol. At necropsy, this was found to be due to tracheal edema
and tissue damage induced by the prolonged pressure contacting
the trachea with the inﬂated endotracheal tube balloon. A lesser
degree of tracheal mucosal impact was then found at scheduled
necropsy of Swine #1. This problem was addressed by incorporat-
ing current recommendations to measure and limit endotracheal
1622 E. Kulstad et al. / Resuscitation 84 (2013) 1619–1624
Table 1
Baseline weights, temperatures, and cooling rates of study subjects.
Swine # Weight (kg) Baseline temperature (◦C) Goal temperature (◦C) Time to goal temperature (min) Cooling rate (◦C/h) Standard deviation at
steady state (◦C)
1 62.8 38.1 34.1 45 1.87 0.10
2 60.8 38.8 34.1 150 1.40 0.03
3 70.3 38.9 34.9 165 1.27 0.15
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t4 68.3 39.2 35.2
5 64.2 38.6 34.6
ube cuff balloon pressure to less than 20 cmH2O during prolonged
ntubation.14
With the exception of Swine #2, all animals were recovered
uccessfully from anesthesia and returned to normal behavioral,
ating, anddrinkinghabits. Three swinewere sacriﬁced3days after
he experimental protocol, and one swine was sacriﬁced 14 days
fter the protocol for gross pathological and histological analysis.
ultiple sections of each esophagus were taken (cranial, mid-
ranial, mid, mid-caudal, caudal, and gastroesophageal junction),
ndother thanmild changes related to gastric acid reﬂuxand reten-
ion after the respiratory arrest of Swine #2, no adverse effects
rom the esophageal heat transfer device were identiﬁed in gross
r histological analyses (Fig. 3).
. Discussion
This study adds further evidence to an initial proof of concept
tudy12 thatmodifying and controlling temperature via heat trans-
er through the esophagus is effective and safe. The design of the
sophageal heat transfer device takes advantage of the robust heat
ransfer environment surrounding the esophagus via the extensive
lood ﬂow from the nearby vena cava, aorta, heart, pulmonary,
nd azygos vessels. Because the esophagus is surrounded by this
arge volume of blood ﬂow, the available heat transfer capacity (via
ig. 2. Temperature versus time plot for the 5 subjects. Vertical lines show initiation poin
he esophageal heat transfer device.150 1.08 0.28
210 1.06 0.48
conduction across the esophagus and subsequent convection
through surrounding blood ﬂow) is large and the effective heat
transfer coefﬁcient is not likely to be diminished with temperature
reduction as it is with skin during surface cooling.
Prior mathematical models13 suggested the possibility of ﬁnd-
ing a higher cooling rate than we encountered; however, models
utilizing Pennes bioheat transfer equation may overestimate the
convective heat transfer coefﬁcient.15 Nevertheless, the cooling
rate achieved by the esophageal heat transfer device compares
favorably with other approaches, exceeding those of most sur-
face contact devices, and matching most reported rates of cooling
in humans with intravascular catheters (0.6–1.7 ◦C/h, with most
reports describing rates between 0.8 and 1.2 ◦C/h).16–23 In addi-
tion, because of the short time required for placement of the device
(less than 1min in our experience), the initiation of cooling can
begin almost immediately after a decision is made to cool with
this approach. Because placement is simple and analogous to that
of standard orogastric tubes, a wide range of healthcare providers
could also place the device without need for physician-level skills.
The lack of shivering seen in the test subjects was unexpected.
Since skin surface receptors are known to play a signiﬁcant role in
the initiation of shivering,24 and skin counter-warming is recom-
mendedas anoption to reduceor eliminate shivering, the induction
of hypothermia through the esophagus may result in avoidance or
t of temperature control (cooling, maintenance, and reversal of hypothermia) with
E. Kulstad et al. / Resuscitation 84 (2013) 1619–1624 1623
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tFig. 3. Histopathology of mid-esophagus of swine at 3-day sacr
eduction of shivering due to the quicker core temperature change
nd a reduction of skin surface receptor activation.
In general, the cooling rate appeared todecreasewitheach study
ubject. Although we cannot ﬁrmly establish the reason for this,
ne possibility is the fact that devices were reused between sub-
ects, and that despite cleaning between uses, contaminant buildup
n the inner or outer walls of the device could have contributed
o diminished performance. The distilled water used in the heat
xchanger for this experiment was not supplemented with the
lgaecide recommended in the user manual, which may addition-
lly have allowed bioﬁlm buildup in the reused devices, adding
urther heat transfer resistance.
Limitations of this study include the fact that we started our
ooling protocol from different start temperatures for each ani-
al and targeted different goal temperatures. We initially planned
o use the same ﬁxed temperature goal for all subjects. However,
ecause swine temperature at baseline variesmore than in humans
ranging from 38 ◦C to almost 40 ◦C, with average of 38.8 ◦C), after
he ﬁrst two subjects had been studied, we subsequently set goal
emperature with this in mind, using a goal of 4 ◦C from each
nimal’s baseline temperature prior to start of inhalational anes-
hesia. We opted for this approach because it avoided possible
isks of subjecting animals to larger (>5 ◦C) temperature decreases
han typically needed in clinical use and the dangers inherent in
emperatures approaching moderate, rather than mild, therapeu-
ic hypothermia, yet still provided the necessary test of the device’s
ffectiveness in inducingmild therapeutic hypothermia.Moreover,
quipoise still exists on what the optimal goal temperature should
e in clinical use, with ongoing and recently completed trials eval-
ating this factor.25,26 Tracheal injury from extended contact with
n endotracheal tube cuff balloon is a well-known phenomenon,27
ut was unfortunately not anticipated by our group at the start of
he study, since long-duration anesthesia and intubation of study
ubjects (a risk factor for tracheal injury) in survival studies is not
ommonly performed. We did not subject to the swine to cardiac
rrest for this study. Although physiologic changes occur post car-
iac arrest, because such a large percentage of total blood volume
ontinues to circulate in close proximity to the esophagus (even
n cases of reduced cardiac output), we would not expect dramatic
hanges inour results if swinewere subjected to cardiac arrest prior
o use.
. ConclusionsA new esophageal device successfully induced, maintained, and
eversed therapeutic hypothermia in large swine. Goal tempera-
ure was maintained within a very narrow range, and thermogenic
1left) and of mid-esophagus of swine at 14-day sacriﬁce (right).
shivering did not occur. These ﬁndings suggest a useful newmodal-
ity to induce therapeutic hypothermia.
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